89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 108 filers reported holding 89BIO INC in Q4 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,526,059 | -3.9% | 98,838 | +17.9% | 0.04% | -24.0% |
Q2 2023 | $1,588,730 | +84.5% | 83,838 | -22.7% | 0.05% | +92.3% |
Q1 2023 | $861,139 | -99.8% | 108,439 | +17.8% | 0.03% | +160.0% |
Q3 2022 | $533,000,000 | – | 92,034 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 11,416,948 | $216,351,165 | 4.08% |
Orchard Capital Management, LLC | 542,879 | $10,287,557 | 3.46% |
Artia Global Partners LP | 465,465 | $8,820,562 | 3.04% |
Octagon Capital Advisors LP | 1,066,784 | $20,215,557 | 2.81% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,393,236 | $45,351,822 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 396,497 | $7,513,618 | 2.32% |
Boxer Capital, LLC | 2,100,000 | $39,795 | 1.85% |
Velan Capital Investment Management LP | 95,000 | $1,800,250 | 1.67% |
Cormorant Asset Management, LP | 1,350,000 | $25,582,500 | 1.43% |
Tri Locum Partners LP | 165,897 | $3,143,748 | 1.17% |